GIBEOM KIM

Company: ShiftBio

Job title: Director, Principal & Researcher

Seminars:

Maximizing Intracellular Delivery by Fusogenic Intrinsic Nanovesicles 1:30 pm

Fusosome platform can specifically fuse to the surface of target cells Fusosome is a platform technology that facilitates membrane-editing and direct delivery of therapeutic cargos into the target cell cytoplasm We reappraised the idea that extracellular vesicles function as garbage cans and repurposed them as a therapeutic agentRead more

day: Day One